We have made several steps in removing injectable promethazine from formulary. Our first step (years ago) was to limit administration to IM or IVPB. Currently, we have removed this product from all Epic order sets and ADM – except for those related to post-op. Can anyone comment on how they dealt with anesthesia’s resistance to formulary removal? The group feels like they cannot afford to lose this agent since we can’t procure droperidol and their options are too limited for PONV. I would love to hear some success stories to provide to this group.
Thanks-
Maria Cumpston, PharmD
Medication Safety Officer
WVU Medicine